Dermata Therapeutics, Inc. [Rocket]

In millions, except per share items	Jun-30-23	Mar-31-23	Jun-30-22	Mar-31-22	Dec-31-21	Sep-30-21	Jun-30-21	Mar-31-21
	10-Q	10-Q	10-Q	10-Q	10-K	S-1	10-Q	10-Q
Operating expenses:
Research and development	0.8	1.2	1.6	1.6	1.1	0.8	0.9	0.7
General and administrative	0.9	1.1	1.1	1.2	1.4	0.9	0.5	1.6
Total operating expenses	1.7	2.3	2.7	2.8	2.6	1.7	1.3	2.3
Loss from operations	-1.7	-2.3	-2.7	-2.8	-2.6	-1.7	-1.3	-2.3

Other income and expenses:
Interest income, net	0.0	0.0				0.0	0.0	0.0
Net loss	-1.7	-2.2	-2.7	-2.8	-2.6	-1.7	-1.3	-2.3

Net loss per share of common stock, basic and diluted	($0.63)	($2.27)	($3.90)	($5.35)	$0.26	($0.86)	($0.70)	($1.21)

Weighted-average basic and diluted common shares	2.7	1.0	0.7	0.5	4.3	5.0	1.9	1.9